US Stocks
/
Indaptus Therapeutics, Inc. Share Price

Indaptus Therapeutics, Inc. Share Price

NASDAQ: INDP
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Indaptus Therapeutics, Inc. Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Indaptus Therapeutics, Inc. Share Price Chart

$0.00$0.00
L
Show Current Price
H

Indaptus Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
$-21.58
Revenue (TTM)
N/A
Return On Equity (TTM)
-661.54%
Profit Margin
N/A
Debt to Equity
1.95
Quarterly Earnings Growth YoY
3.06%

Indaptus Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$3.81M-$4.02M-$3.07M-$4.53M-$5.23M-$2.98M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A-5.48%23.57%-47.68%-15.37%43.10%

Indaptus Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
RevenueN/AN/AN/AN/AN/A
Net Profit-$7.71M-$14.32M-$15.42M-$15.02M-$20.85M
Net Profit MarginN/AN/AN/AN/AN/A
Income ChangeN/A-85.74%-7.68%2.60%-38.79%

About Indaptus Therapeutics, Inc.

Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.

Indaptus Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %

INDP Share Price FAQs

What is Indaptus Therapeutics, Inc. share price today?

chevron-up
Indaptus Therapeutics, Inc. share price today is $0.00 as on August 9, 2026 at 11:11 am IST.

What is the 52 week high and 52 week low of Indaptus Therapeutics, Inc. stock?

chevron-up
52 week high/low data for Indaptus Therapeutics, Inc. is currently unavailable.

What is INDP's net income for the last quarter?

chevron-up
INDP's net income for the last quarter is -0.00B USD.

Can I buy INDP shares in India?

chevron-up
Yes. You can buy INDP in India by opening an international trading account.